等待开盘 10-31 09:30:00 美东时间
-0.400
-1.96%
今日重点评级关注:Canaccord Genuity:维持Wave Life Sciences"买入"评级,目标价从42美元升至44美元;Canaccord Genuity:维持Pharming Group"买入"评级,目标价从38美元升至41美元
10-30 12:30
10月30日,博士伦(BLCO)收平,报20.4美元,成交额7149.59万美元,市值72.86亿美元。 行情数据 • 开盘价:20.89美元 • 最高价:2...
10-30 04:59
Wells Fargo analyst Larry Biegelsen maintains Bausch & Lomb (NYSE:BLCO) with a Equal-Weight and raises the price target from $18 to $19.
10-29 22:03
在制药和外科植入物业务的带动下,博士伦(Bausch + Lomb)第三季度销售额增长7%,调整后EBITDA增长34%,公司随后上调了2026年营收和调整后EBITDA指引。
10-29 00:02
专题:聚焦美股2026年第三季度财报 这家眼部健康企业预计全年营收为 54.5‑55.5 亿美元,此前预期为 54.4‑55.4 亿美元...
10-28 22:49
Bausch & Lomb (NYSE:BLCO) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.22 by 54.55 percent. This is a 88.89 percent increase over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $1.375 billion which...
10-28 18:58
10月27日,博士伦(BLCO)收涨0.63%,报17.58美元,成交额878.7万美元,市值62.79亿美元。 行情数据 • 开盘价:17.41美元 • 最高...
10-27 05:02
Dan Loeb‘s Third Point opened a position in Bausch + Lomb Corp. (NYSE:BLCO) in the second quarter, buying around 85,000 shares, valued at about $1.4 million, as of June 30. Recent News: On Oct. 12, Bausch + Lomb announced that Thomas J. Appio has been appointed interim CEO of Bausch + Lomb, effectiv...
10-20 02:46
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:04
(来源:医疗器械创新网) 2026年10月12日,全球眼健康领域的头部企业博士伦(Bausch + Lomb,NYSE/TSX:BLCO)对外公布,其&nbs...
10-13 17:00